Literature DB >> 19777527

Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily.

Colleen Pelser1, Francesco Vitale, Denise Whitby, Barry I Graubard, Angelo Messina, Lorenzo Gafà, Elizabeth E Brown, Lesley A Anderson, Nino Romano, Carmela Lauria, James J Goedert.   

Abstract

The virus that causes Kaposi sarcoma, KS-associated herpesvirus (KSHV, also known as human herpesvirus 8) has an unusual distribution and poorly characterized modes of transmission. To clarify these issues, socio-demographic correlates of KSHV seroprevalence were examined in a population-based study. In 1,154 randomly sampled adults (aged 32- 92, mean 71 years) throughout Sicily, KSHV antibodies were detected with four assays and a conservative algorithm. Seroprevalence was re-weighted to the population. Odds ratios with 95% confidence intervals (OR, CI) from multivariate logistic regression were used to estimate associations of seroprevalence with interview data. KSHV seroprevalence was 8.5%, including 5.3% among men (N = 848) and 11.5% among women (N = 306, P = 0.22). Seroprevalence was higher with residence in a smaller community during childhood (P(trend) = 0.03) and working with plants/soil during adulthood (OR 2.9, CI 1.1-7.9); these were especially strong among women. Among men, seroprevalence was significantly associated with lower education (OR 2.6, CI 1.1-5.9) and migration to a larger community (OR 0.3, CI 0.1-0.9). Other demographic and household variables were unrelated to seroprevalence. From these data, KSHV in Sicily appears to be related to low socio-economic status, but micro-endemicity in small communities cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19777527      PMCID: PMC2784645          DOI: 10.1002/jmv.21589

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.

Authors:  E A Engels; D Whitby; P B Goebel; A Stossel; D Waters; A Pintus; L Contu; R J Biggar; J J Goedert
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-01       Impact factor: 3.731

2.  Geographic variation in human herpesvirus 8 seroprevalence and possible association with exposure to bites from blood-sucking arthropods.

Authors:  Valeria Ascoli; Daniela Manno; Mario Coluzzi
Journal:  J Infect Dis       Date:  2006-08-01       Impact factor: 5.226

3.  Environmental factors influence the rate of human herpesvirus type 8 infection in a population with high incidence of classic Kaposi sarcoma.

Authors:  Antonio Angeloni; Maria Vittoria Masala; Maria Antonietta Montesu; Roberta Santarelli; Rosanna Satta; Luca Ceccherini-Nelli; Paola Valdivieso; Alberto Faggioni; Francesca Cottoni
Journal:  Clin Infect Dis       Date:  2006-02-27       Impact factor: 9.079

4.  Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia.

Authors:  D Serraino; D Cerimele; P Piselli; L Aztori; F Farchi; F Carletti; A Navarra; M V Masala; G Rezza
Journal:  Infection       Date:  2006-02       Impact factor: 3.553

5.  Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers.

Authors:  Sam M Mbulaiteye; Robert J Biggar; Ruth M Pfeiffer; Paul M Bakaki; Christine Gamache; Anchilla M Owor; Edward Katongole-Mbidde; Christopher M Ndugwa; James J Goedert; Denise Whitby; Eric A Engels
Journal:  J Acquir Immune Defic Syndr       Date:  2005-04-01       Impact factor: 3.731

6.  Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma.

Authors:  Elisabetta Tanzi; Alessandra Zappa; Fausta Caramaschi; Antonella Amendola; Donatella Lasagna; Luciana Gatti; Valeria Ascoli; Giovanni Rezza; Alessandro R Zanetti
Journal:  J Med Virol       Date:  2005-08       Impact factor: 2.327

7.  The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.

Authors:  Robert Newton; John Ziegler; Dimitra Bourboulia; Delphine Casabonne; Valerie Beral; Edward Mbidde; Lucy Carpenter; Gillian Reeves; D Maxwell Parkin; Henry Wabinga; Sam Mbulaiteye; Harold Jaffe; Robin Weiss; Chris Boshoff
Journal:  Int J Cancer       Date:  2003-01-10       Impact factor: 7.396

8.  Mucosal shedding of human herpesvirus 8 in men.

Authors:  J Pauk; M L Huang; S J Brodie; A Wald; D M Koelle; T Schacker; C Celum; S Selke; L Corey
Journal:  N Engl J Med       Date:  2000-11-09       Impact factor: 91.245

9.  High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs.

Authors:  Sam M Mbulaiteye; Michael Walters; Eric A Engels; Paul M Bakaki; Christopher M Ndugwa; Anchilla M Owor; James J Goedert; Denise Whitby; Robert J Biggar
Journal:  J Infect Dis       Date:  2005-12-22       Impact factor: 5.226

10.  Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host.

Authors:  Sam Mbulaiteye; Vickie Marshall; Rachel K Bagni; Cheng-Dian Wang; Georgina Mbisa; Paul M Bakaki; Anchilla M Owor; Christopher M Ndugwa; Eric A Engels; Edward Katongole-Mbidde; Robert J Biggar; Denise Whitby
Journal:  J Infect Dis       Date:  2006-03-17       Impact factor: 5.226

View more
  5 in total

1.  Ultraviolet Radiation and Kaposi Sarcoma Incidence in a Nationwide US Cohort of HIV-Infected Men.

Authors:  Elizabeth K Cahoon; Eric A Engels; D Michal Freedman; Mary Norval; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

Review 2.  HIV-associated Kaposi sarcoma and related diseases.

Authors:  Priscila H Gonçalves; Thomas S Uldrick; Robert Yarchoan
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

3.  Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily.

Authors:  James J Goedert; Giuseppe Calamusa; Carmelo Dazzi; Anna Perna; Colleen Pelser; Lesley A Anderson; Camille Madsen; Liliana R Preiss; Matt Airola; Barry I Graubard; Angelo Messina; Carmela Lauria; Nino Romano
Journal:  Infect Agent Cancer       Date:  2010-12-02       Impact factor: 2.965

4.  Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls.

Authors:  R M Valenti; E Amodio; J-M Nam; L Preiss; B I Graubard; N Romano; J J Goedert
Journal:  Br J Cancer       Date:  2011-01-18       Impact factor: 7.640

5.  Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China.

Authors:  Hui Wang; Jian Liu; Liang Li; Zhihui Ren; Hao Wen; Xing Wang
Journal:  Virol J       Date:  2011-12-14       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.